rise
expert
toll
exam
widely
ABSTRACT
eur
align
parameter
guide
future
record
liver
brenner
MM
zhang
kartika
assessed
affect
comparative
about
early
necrosi
yerushalmi
jia
andy
definition
poorer
despite
examination
overall
000
syarat_khusus_dr
related
comorbiditie
overexpression
match
also
lymph
APJCP
blurred
average
easier
majority
oestrogen
vol
zhu
planning
portal
death
FL
exposure
your
limit
2017
evaluate
term
around
organ
morphology
platelet
compton
something
develop
latief
statement
hospital
3274569659
either
developing
recommend
offer
BMC
trastuzumab
who
re
obesity
good
winer
leading
due
prognosi
microcirc
masse
text
diversity
care
approved
affected
rarely
fatal
apr
unlike
improving
ultrasonographic
ijrpr
would
observation
tend
separate
TYPE
radiology
tended
1024
patche
key
elderly
population
independent
SINA
universita
increased
cell
greene
RK
progression
exhibited
variable
neovascularization
decrease
enriched
conspicuou
receptor
evaluated
risk
large
easily
identified
visible
not
account
reviewed
providing
US
particularly
RD
189
six
contrary
eighth
manipulation
http
AM
kartika2
including
tendency
relevant
shift
radiologically
focu
shofiyah
issue
VI
prolonged
thuerlimann
represent
advanced
paclitaxel
basic
surgery
molecular
WA
approximately
aberrant
therapeutic
contribute
symptom
combination
fan
lung
example
genomic
overexpres
fact
deeper
551
proteomic
new
correlational
hung
database
among
2021
ari
exist
337
simple
fulvestrant
very
shown
precise
ki67
chula
550
KF
NNH
final
problem
reported
851
KB
diseasedb
each
wahidin
CA
detection
displayed
CONCLUSION
university
333
system'
course
high
qualitie
DCIS
byrd
noticeable
submitted
retrospective
epidermal
integrity
flag
discussion
there
entirely
metastasi
NA
content
angiogenesi
smaller
lodi
histological
novel
chung
play
INTRODUCTION
causing
oval
edge
mol
incidence
medical
radiol
versu
local
center
egypt
lump
based
djuwita
596
UMI
room
overview
diagnosi
well
tikrit
document
any
physical
recognized
personalized
yan
MK
kementerian
alqahtani
criteria
internet
858
initial
haye
surrounding
reaching
DIABETES
org
applicability
2226
emphasizing
CT
imaging
page
2199
echogenicity
profile
algorithm
radiological
pattern
identification
invasion
strategie
greater
divided
familie
DJ
used
highest
count
volume
table
according
coronary
AA
MELLITUS
localisation
margin
xuesong
change
lymphatic
notice
LCIS
recognizing
hypoechoic
turnitin
multifocal
beyond
microscopic
solid
pure
jian
restrict
epidemiol
presence
implication
hormone
ibnu
identifying
washington
mostly
gene
found
out
centimeter
methylator
publication
altered
JE
jurnal
uea
100565
degree
measured
2022
lin
minimal
cover
little
HOSPITAL
gro
goldhirsch
face
multifocality
umi
evaluation
heal
undergoing
clinico
top
mark
sedentary
global
via
mikhail
lymphocyte
interest
treated
wherea
pathological
genetic
gelmon
706
coate
carried
2014
lembo
positive
longitudinal
activity
level
precision
area
absolute
830
referral
percutaneou
impact
elma
assessment
participant
spread
HM
master
com
enhance
kuo
women
hormonal
syndrome
histopathological
testing
several
les
small
MG
elmika
548
absent
differentiated
through
549
predominantly
kesehatan
other
indek
inference
invasivenes
importance
approache
necessarily
epigenetic
usually
poorly
pre
contrast
makassar
contraceptive
group
associated
carcinoma
cardiol
eribulin
using
turner
therapy
specific
seen
remain
clinically
vital
low
region
localization
mas
annual
case
round
grade
amin
neoadjuvant
show
baghdad
tumor
random
observed
paper
further
nor
AJCC
making
HER2
pathologic
exhibiting
research
ha
diameter
intervention
ethic
estrogen
boundarie
value
jneonatalsurg
subtype
mortality
infiltrative
data
echo
slamon
notable
causal
ultrasound
understanding
approval
department
program
biological
2025
student
typically
huanfeng
pengwei
muslim
may
collected
martelli
visi
protocol
included
frontiersin
human
national
sulawesi
identify
commonly
demonstrated
uneven
limitation
socioeconomic
clearly
aiuto
generalizability
comparing
springer
cohort
within
strongly
ravdin
study
journal
our
cancer
natural
GMT
expression
different
xie
attenuated
island
disparitie
gap
studie
free
ductal
overlapping
tracking
index
worldwide
marked
detectable
reviewing
still
430
infiltration
agency
latief1
consisted
matche
late
cappelletti
present
relationship
micro
reix
involvement
consensu
nab
reveal
plainly
aggressivenes
BRCA1
fukada
wood
it
build
but
set
sina
166
non
228
than
method
normal
comprehensive
prev
apart
increase
RESULTS
most
MR
diagnostic
1380
enlargement
assessing
could
consistency
metastatic
IBNU
ito
personalizing
like
limiting
outcome
DR
ranging
engl
improve
kobayashi
locally
CC
worse
enlarged
determined
long
piccart
resistance
rate
theja
poor
similar
lesion
word
predominate
multicentric
manual
chih
carin
more
just
neonatal
indicate
indistinct
breast
conversely
tissue
year
old
imamura
having
varie
jakarta
oncol
bibliography
management
file
primary
cuir
wei
IA
ISSN
structure
selection
concern
BRCA2
email
linked
profiling
palbociclib
progesterone
board
0439
limfovaskular
finding
negative
metagene
cause
sample
lumpectomy
irregular
SB
funding
marker
lack
target
strange
deeply
strong
localised
ethical
between
MS
confirmed
centre
support
hazy
budijitno
reducing
diva
pathophysiology
arabia
abnormal
213
thiebaut
invading
547
compared
age
prominent
additionally
discussed
homogeneou
wen
indonesianjournalmedicine
possibly
they
potential
med
moderate
current
appearance
2010
pdf
hypervascular
khaled
chang
cite
mammography
642
biology
suspiciou
morphologically
437971
drop
contribution
world
staging
detailed
committee
asses
previou
119
nakano
positivity
ranking
regional
sampling
higher
metastase
suwondo
546
number
characterized
significantly
luminal
larger
citation
systematic
distant
additional
will
1926
morbidity
all
province
system
pacific
treatment
international
callari
adisasmita
advance
hemorheol
selamat
prevalent
adjuvant
important
IV
uniform
dose
tailored
tool
insight
doppler
had
author
BRG
south
similarity
exhibit
necrotic
invasive
result
descriptive
gelber
continuing
older
appear
reflecting
oid
significance
accuracy
differentiation
conducted
surgical
technique
int
PET
phenotype
jakubowski
23
severe
attention
MAKASSAR
difference
immunohistochemistry
being
anatomic
appl
GCO
prognostic
2013
extremely
tumour
resolution
biol
female
measure
fulfilled
shape
look
lobular
III
araki
survival
jinjun
estimated
approach
clin
lijun
2206
miyagawa
cited
design
MH
DISCUSSION
quantitative
follow
2023
rahman
pei
statistical
correlation
their
showing
morphological
treat
demonstrate
aggressive
distinction
gebhart
brookland
asian
keyword
considerable
size
critical
unclear
likelihood
histopathology
decision
after
payudara
detected
instance
multicenter
material
lifestyle
wang
RI
analysi
NC
registry
indicating
wall
screening
period
115
republik
information
filtered
them
scan
microcalcification
disclosure
ann
delayed
total
cros
reflect
showed
thorough
proliferation
underscore
gathered
type
recurrence
clear
indonesia
characteristic
crucial
mechanobiology
indicator
furthermore
shofy
into
few
sign
lancet
apparent
essential
2020
include
while
routine
macrocalcification
PM
association
variation
full
MB
lympho
caregiver
mutation
obviou
lymphovascular
such
although
notably
combined
kamel
clarify
two
submission
musella
imaginng
KEP
latency
379
disease
optimizing
lower
declare
download
predominating
predictive
statu
diferensiation
postmenopausal
individual
consistent
development
frequently
often
solitary
none
control
yin
recommended
situ
rug
USG
2004
history
metabolic
174
faculty
ibrahim
health
peng
acros
KA
setting
big
657
wa
2018
missing
power
scheer
protein
hoffmeister
we'd
influencing
neither
review
mechanism
2016
organization
likely
regular
firm
hand
significant
especially
kanker
edition
dramatically
frequent
heitz
name
acknowledgement
2024
ultrasonography
ueaeprint
depending
REFERENCES
METHOD
healthcare
vascularization
quotation
accompanied
oral
clinicopathological
masuda
response
conclusion
time
vascular
trn
guiding
grading
work
MA
feature
growth
painles
internal
sectional
homogen
tailoring
inconsistencie
node
tseng
both
enhanced
highlight
contributed
sheet
presented
colorectal
bridge
jun
quoted
ANEM
gershenwald
233
markedly
defined
observatory
hsuan
685
introduction
cpg
baraka
prevent
presentation
report
bioeng
AS
online
clopidogrel
prediction
intermediate
medshun
consisting
seem
character
plu
calcification
choice
distinct
preoperative
propertie
proliferative
gao
TM
surg
differ
ID
variou
averaging
yen
source
petel
major
bigger
diagnose
inhibition
conflict
role
www
gallen
saudi
appeared
biomarker
neovascularisation
patient
resistin
597
pertuzumab
instability
bondarenko
available
EP
common
revealed
derived
respectively
challenge
factor
date
confined
detail
similarly
however
clinical
car
involve
stage
single
552